Browse by Audience
MEMBER

Update Your Profile
Member Spotlights
Refer a Member: IASP Champions
Join a Special Interest Group (SIG)
Find a Chapter
Join Now

RESEARCHER

PAIN
PAIN Reports
Pain Research Forum
Papers of the Week
Webinars and Podcasts
Events

HEALTH CARE PROVIDER

Online Learning - PERC
Webinars & Podcasts
Curricula
Graduate Opportunities
Events

PATIENT & CAREGIVER

RELIEF News
Resources for Living with Pain
Global Alliance of Partners in Pain Advocacy (GAPPA)
Events

PARTNER

Support IASP
Sponsor an Event
Become a Partner

gy2022-1-3
I am a
IASP Logo
Home I AM A Search Login

Papers of the Week

Home / Publications / Pain Research Forum / Papers of the Week / Treatment data from the Brazilian fibromyalgia registry (EpiFibro).

< BACK TO ARCHIVE


Papers: 18 Jan 2020 - 24 Jan 2020


Human Studies


2020 01 21


Adv Rheumatol


http://www.ncbi.nlm.nih.gov/pubmed/31964420?dopt=Abstract


60


1

Treatment data from the Brazilian fibromyalgia registry (EpiFibro).

Authors

Treatment data from the Brazilian fibromyalgia registry (EpiFibro).
de Assis M R, Paiva E D S, Helfenstein M, Heymann R E, Pollak D F, Provenza J R, Ranzolin A, Rezende M C, Ribeiro L S, Souza E JR, Martinez J E
Adv Rheumatol. 2020 01 21; 60(1):9.
PMID: 31964420.

Abstract

EpiFibro (Brazilian Epidemiological Study of Fibromyalgia) was created to study patients with fibromyalgia (FM). Patients were included since 2011 according to the classification criteria for FM of the American College of Rheumatology of 1990 (ACR1990).
Read This Paper